Alfresa Holdings Corporation (Alfresa Group) is a holding firm that manages companies carrying out the business of wholesale trade, manufacture, commercialization and import/export of pharmaceuticals, diagnostic reagents and medical equipment. It operates through two reportable business segments, namely, Wholesaling Business and Manufacturing Business. The group's product portfolio includes over-the-counter drugs, ethical pharmaceuticals, diagnostic reagents and medical devices. It operates along with its subsidiaries in Japan. Alfresa Group is headquartered in Tokyo, Japan.
The group plans to strengthen and enhance its business. This intent is visible as it recently concluded the transfer of its self-medication products wholesale business from Ryuyaku Co., Ltd. to Alfresa Healthcare Corporation.